Review



microscan autoscan 4 system  (Dade Behring)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Dade Behring microscan autoscan 4 system
    Microscan Autoscan 4 System, supplied by Dade Behring, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/microscan+system/pm41942599-48-13-17
    Average 86 stars, based on 1 article reviews
    microscan autoscan 4 system - by Bioz Stars, 2026-09
    86/100 stars

    Images

    Related Articles

    Northern Blot:

    Article Title: Pharmacodynamic evaluation of suppression of in vitro resistance in Acinetobacter baumannii strains using polymyxin B-based combination therapy
    Article Snippet: Identification and antimicrobial susceptibility profiles of bacterial isolates were performed by routine automated microbiology systems, such as Phoenix ® (BD Diagnostic Systems, Sparks, MD) and MicroScan® (DadeBehring, West Sacramento, CA) according to the equipment's instructions.

    Article Title: Enterococcus raffinosus bacteremia: clinical experience with 49 adult patients.
    Article Snippet: This study is to evaluate the clinical characteristics and outcomes of Enterococcus raffinosus bacteremia in adults.. We analyzed the medical records of adult patients with E. raffinosus bacteremia who were diagnosed and treated between 1997 and 2020 at a tertiary care teaching hospital in Seoul, Republic of Korea.. The demographic, clinical, and laboratory data were collected and assessed.

    Article Title: Changes in the characteristics of community-onset fluoroquinolone-resistant Escherichia coli isolates causing community-acquired acute pyelonephritis in South Korea.
    Article Snippet: The bacterial species and their susceptibilities to antibiotics were determined using a semi-automated system (VITEK, bioMèrieux, Hazelwood, MO, USA, or Microscan, Dade Behring, West Sacramento, CA, USA).

    Article Title: Clinical impact of and microbiological risk factors for qacA/B positivity in ICU-acquired ST5-methicillin-resistant SCC mec type II Staphylococcus aureus bacteremia
    Article Snippet: Antimicrobial susceptibilities were determined with a MicroScan (Dade Behring, West Sacramento, CA, USA) and the standard criteria of the Clinical and Laboratory Standards Institute (CLSI) .

    Diffusion-based Assay:

    Article Title: Pharmacodynamic evaluation of suppression of in vitro resistance in Acinetobacter baumannii strains using polymyxin B-based combination therapy
    Article Snippet: Identification and antimicrobial susceptibility profiles of bacterial isolates were performed by routine automated microbiology systems, such as Phoenix ® (BD Diagnostic Systems, Sparks, MD) and MicroScan® (DadeBehring, West Sacramento, CA) according to the equipment's instructions.

    Article Title: Enterococcus raffinosus bacteremia: clinical experience with 49 adult patients.
    Article Snippet: This study is to evaluate the clinical characteristics and outcomes of Enterococcus raffinosus bacteremia in adults.. We analyzed the medical records of adult patients with E. raffinosus bacteremia who were diagnosed and treated between 1997 and 2020 at a tertiary care teaching hospital in Seoul, Republic of Korea.. The demographic, clinical, and laboratory data were collected and assessed.

    Article Title: Changes in the characteristics of community-onset fluoroquinolone-resistant Escherichia coli isolates causing community-acquired acute pyelonephritis in South Korea.
    Article Snippet: The bacterial species and their susceptibilities to antibiotics were determined using a semi-automated system (VITEK, bioMèrieux, Hazelwood, MO, USA, or Microscan, Dade Behring, West Sacramento, CA, USA).

    Article Title: Clinical impact of and microbiological risk factors for qacA/B positivity in ICU-acquired ST5-methicillin-resistant SCC mec type II Staphylococcus aureus bacteremia
    Article Snippet: Antimicrobial susceptibilities were determined with a MicroScan (Dade Behring, West Sacramento, CA, USA) and the standard criteria of the Clinical and Laboratory Standards Institute (CLSI) .

    Modification:

    Article Title: Pharmacodynamic evaluation of suppression of in vitro resistance in Acinetobacter baumannii strains using polymyxin B-based combination therapy
    Article Snippet: Identification and antimicrobial susceptibility profiles of bacterial isolates were performed by routine automated microbiology systems, such as Phoenix ® (BD Diagnostic Systems, Sparks, MD) and MicroScan® (DadeBehring, West Sacramento, CA) according to the equipment's instructions.

    Article Title: Enterococcus raffinosus bacteremia: clinical experience with 49 adult patients.
    Article Snippet: This study is to evaluate the clinical characteristics and outcomes of Enterococcus raffinosus bacteremia in adults.. We analyzed the medical records of adult patients with E. raffinosus bacteremia who were diagnosed and treated between 1997 and 2020 at a tertiary care teaching hospital in Seoul, Republic of Korea.. The demographic, clinical, and laboratory data were collected and assessed.

    Article Title: Changes in the characteristics of community-onset fluoroquinolone-resistant Escherichia coli isolates causing community-acquired acute pyelonephritis in South Korea.
    Article Snippet: The bacterial species and their susceptibilities to antibiotics were determined using a semi-automated system (VITEK, bioMèrieux, Hazelwood, MO, USA, or Microscan, Dade Behring, West Sacramento, CA, USA).

    Article Title: Clinical impact of and microbiological risk factors for qacA/B positivity in ICU-acquired ST5-methicillin-resistant SCC mec type II Staphylococcus aureus bacteremia
    Article Snippet: Antimicrobial susceptibilities were determined with a MicroScan (Dade Behring, West Sacramento, CA, USA) and the standard criteria of the Clinical and Laboratory Standards Institute (CLSI) .



    Similar Products

    microscan walkaway 40 system  (Siemens Healthineers)
    86
    Siemens Healthineers microscan walkaway 40 system
    Microscan Walkaway 40 System, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/microscan+system+walkaway/pm41943907-54-11-15
    Average 86 stars, based on 1 article reviews
    microscan walkaway 40 system - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    microscan autoscan 4 system  (Dade Behring)
    86
    Dade Behring microscan autoscan 4 system
    Microscan Autoscan 4 System, supplied by Dade Behring, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/microscan+system/pm41942599-48-13-17
    Average 86 stars, based on 1 article reviews
    microscan autoscan 4 system - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    mhz microscan transducer  (FUJIFILM VisualSonics Inc)
    86
    FUJIFILM VisualSonics Inc mhz microscan transducer
    Mhz Microscan Transducer, supplied by FUJIFILM VisualSonics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/pm41807690-218-17-8
    Average 86 stars, based on 1 article reviews
    mhz microscan transducer - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    microscan walkway 96 system  (Siemens Healthineers)
    86
    Siemens Healthineers microscan walkway 96 system
    Microscan Walkway 96 System, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/96+instrument+walkaway/pmc13006696-46-13-17
    Average 86 stars, based on 1 article reviews
    microscan walkway 96 system - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    microscan walkaway 96 plus automated microbial susceptibility system  (Siemens Healthineers)
    86
    Siemens Healthineers microscan walkaway 96 plus automated microbial susceptibility system
    Microscan Walkaway 96 Plus Automated Microbial Susceptibility System, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/96+instrument+walkaway/pmc12997785-33-5-13
    Average 86 stars, based on 1 article reviews
    microscan walkaway 96 plus automated microbial susceptibility system - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    mhz microscan linear ultrasound imaging array  (FUJIFILM VisualSonics Inc)
    86
    FUJIFILM VisualSonics Inc mhz microscan linear ultrasound imaging array
    (A) CAD rendering of custom <t>ultrasound-guided</t> FUS system consisting of a 4-element 3.78 MHz transducer axially co-registered with 15 MHz <t>MicroScan</t> linear ultrasound imaging array. (B) Representative partial ablation scheme and (C) B-mode ultrasound images of E0771 tumor either before/during (top) or after (bottom) T-FUS treatment, with hyperechoic signature present after treatment (arrow). (D) Custom grading scale of presence of hyperechoic signal post-T-FUS treatment across all murine breast cancer models. (E) Overview of experimental timeline. (F) Representative H&E staining, along with cleaved caspase 3, PARP, and HSP70 staining, was performed on control and T-FUS-treated E0771 tumors 24 hours post-treatment. (G) In vivo surrogate measurements of ATP levels via bioluminescence at 10 minutes after T-FUS. (H) Temporal radiance curve (proxying relative ATP levels) for a sham vs. tumor volume-matched T-FUS mice (E0771 model). Significance assessed by Wilcoxon rank-sum test. **p=0.0028. H-L) (I) Percentage of B cells (CD19 + , MHCII + ), (J) macrophages (MФs; F480 + , Ly6C - ), (K) cDCs (CD11c + , MHCII + ), (L) monocytes (F480 + , Ly6C + ), and (M) granulocytes (CD11b + , Ly6G + ) out of CD45+ cells in the tumor. Significance assessed by Welch’s T-test.*p < 0.05, **p < 0.01, and ***p < 0.001 vs. control, respectively.
    Mhz Microscan Linear Ultrasound Imaging Array, supplied by FUJIFILM VisualSonics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/bio_rxiv__64898__2026__03__02__708396-201-26-33
    Average 86 stars, based on 1 article reviews
    mhz microscan linear ultrasound imaging array - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    microscan walkaway 96 plus system  (Siemens Healthineers)
    86
    Siemens Healthineers microscan walkaway 96 plus system
    (A) CAD rendering of custom <t>ultrasound-guided</t> FUS system consisting of a 4-element 3.78 MHz transducer axially co-registered with 15 MHz <t>MicroScan</t> linear ultrasound imaging array. (B) Representative partial ablation scheme and (C) B-mode ultrasound images of E0771 tumor either before/during (top) or after (bottom) T-FUS treatment, with hyperechoic signature present after treatment (arrow). (D) Custom grading scale of presence of hyperechoic signal post-T-FUS treatment across all murine breast cancer models. (E) Overview of experimental timeline. (F) Representative H&E staining, along with cleaved caspase 3, PARP, and HSP70 staining, was performed on control and T-FUS-treated E0771 tumors 24 hours post-treatment. (G) In vivo surrogate measurements of ATP levels via bioluminescence at 10 minutes after T-FUS. (H) Temporal radiance curve (proxying relative ATP levels) for a sham vs. tumor volume-matched T-FUS mice (E0771 model). Significance assessed by Wilcoxon rank-sum test. **p=0.0028. H-L) (I) Percentage of B cells (CD19 + , MHCII + ), (J) macrophages (MФs; F480 + , Ly6C - ), (K) cDCs (CD11c + , MHCII + ), (L) monocytes (F480 + , Ly6C + ), and (M) granulocytes (CD11b + , Ly6G + ) out of CD45+ cells in the tumor. Significance assessed by Welch’s T-test.*p < 0.05, **p < 0.01, and ***p < 0.001 vs. control, respectively.
    Microscan Walkaway 96 Plus System, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/96+instrument+walkaway/bio_rxiv__64898__2025__12__30__696967-48-10-14
    Average 86 stars, based on 1 article reviews
    microscan walkaway 96 plus system - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    microscan system  (Dade Behring)
    86
    Dade Behring microscan system
    (A) CAD rendering of custom <t>ultrasound-guided</t> FUS system consisting of a 4-element 3.78 MHz transducer axially co-registered with 15 MHz <t>MicroScan</t> linear ultrasound imaging array. (B) Representative partial ablation scheme and (C) B-mode ultrasound images of E0771 tumor either before/during (top) or after (bottom) T-FUS treatment, with hyperechoic signature present after treatment (arrow). (D) Custom grading scale of presence of hyperechoic signal post-T-FUS treatment across all murine breast cancer models. (E) Overview of experimental timeline. (F) Representative H&E staining, along with cleaved caspase 3, PARP, and HSP70 staining, was performed on control and T-FUS-treated E0771 tumors 24 hours post-treatment. (G) In vivo surrogate measurements of ATP levels via bioluminescence at 10 minutes after T-FUS. (H) Temporal radiance curve (proxying relative ATP levels) for a sham vs. tumor volume-matched T-FUS mice (E0771 model). Significance assessed by Wilcoxon rank-sum test. **p=0.0028. H-L) (I) Percentage of B cells (CD19 + , MHCII + ), (J) macrophages (MФs; F480 + , Ly6C - ), (K) cDCs (CD11c + , MHCII + ), (L) monocytes (F480 + , Ly6C + ), and (M) granulocytes (CD11b + , Ly6G + ) out of CD45+ cells in the tumor. Significance assessed by Welch’s T-test.*p < 0.05, **p < 0.01, and ***p < 0.001 vs. control, respectively.
    Microscan System, supplied by Dade Behring, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/microscan+system/pm41387691-161-8-10
    Average 86 stars, based on 1 article reviews
    microscan system - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) CAD rendering of custom ultrasound-guided FUS system consisting of a 4-element 3.78 MHz transducer axially co-registered with 15 MHz MicroScan linear ultrasound imaging array. (B) Representative partial ablation scheme and (C) B-mode ultrasound images of E0771 tumor either before/during (top) or after (bottom) T-FUS treatment, with hyperechoic signature present after treatment (arrow). (D) Custom grading scale of presence of hyperechoic signal post-T-FUS treatment across all murine breast cancer models. (E) Overview of experimental timeline. (F) Representative H&E staining, along with cleaved caspase 3, PARP, and HSP70 staining, was performed on control and T-FUS-treated E0771 tumors 24 hours post-treatment. (G) In vivo surrogate measurements of ATP levels via bioluminescence at 10 minutes after T-FUS. (H) Temporal radiance curve (proxying relative ATP levels) for a sham vs. tumor volume-matched T-FUS mice (E0771 model). Significance assessed by Wilcoxon rank-sum test. **p=0.0028. H-L) (I) Percentage of B cells (CD19 + , MHCII + ), (J) macrophages (MФs; F480 + , Ly6C - ), (K) cDCs (CD11c + , MHCII + ), (L) monocytes (F480 + , Ly6C + ), and (M) granulocytes (CD11b + , Ly6G + ) out of CD45+ cells in the tumor. Significance assessed by Welch’s T-test.*p < 0.05, **p < 0.01, and ***p < 0.001 vs. control, respectively.

    Journal: bioRxiv

    Article Title: Focused Ultrasound Thermal Ablation and CD40 Agonism Reprograms Breast Tumor Immunity to Drive Regression and Memory

    doi: 10.64898/2026.03.02.708396

    Figure Lengend Snippet: (A) CAD rendering of custom ultrasound-guided FUS system consisting of a 4-element 3.78 MHz transducer axially co-registered with 15 MHz MicroScan linear ultrasound imaging array. (B) Representative partial ablation scheme and (C) B-mode ultrasound images of E0771 tumor either before/during (top) or after (bottom) T-FUS treatment, with hyperechoic signature present after treatment (arrow). (D) Custom grading scale of presence of hyperechoic signal post-T-FUS treatment across all murine breast cancer models. (E) Overview of experimental timeline. (F) Representative H&E staining, along with cleaved caspase 3, PARP, and HSP70 staining, was performed on control and T-FUS-treated E0771 tumors 24 hours post-treatment. (G) In vivo surrogate measurements of ATP levels via bioluminescence at 10 minutes after T-FUS. (H) Temporal radiance curve (proxying relative ATP levels) for a sham vs. tumor volume-matched T-FUS mice (E0771 model). Significance assessed by Wilcoxon rank-sum test. **p=0.0028. H-L) (I) Percentage of B cells (CD19 + , MHCII + ), (J) macrophages (MФs; F480 + , Ly6C - ), (K) cDCs (CD11c + , MHCII + ), (L) monocytes (F480 + , Ly6C + ), and (M) granulocytes (CD11b + , Ly6G + ) out of CD45+ cells in the tumor. Significance assessed by Welch’s T-test.*p < 0.05, **p < 0.01, and ***p < 0.001 vs. control, respectively.

    Article Snippet: The system was powered by a 200W amplifier (Electronics & Innovation 1020L) driven by an arbitrary function generator (Tektronix AFG3022C), and axially co-registered to a 15 MHz MicroScan linear ultrasound imaging array (MS200; VisualSonics).

    Techniques: Imaging, Staining, Control, In Vivo